Preferred Label : Fidanacogene Elaparvovec;

UNII : 413EU9081Y;

CAS number : 1954659-47-2;

NCI Metathesaurus CUI : CL1405979;

Details


Keyword's position in hierarchy(ies) : arborescence

Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/beqvez
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
Fidanacogene Elaparvovec
Fidanacogene Elaparvovec
fidanacogene elaparvovec
drug approval
europe
Gene Therapy Agents
Gene Therapy Agents
hemophilia B
infusions, intravenous
continuity of patient care
Infusion-Related Reaction
factor IX
product surveillance, postmarketing
risk management
drug interactions
Female of Childbearing Potential
pregnancy
breast feeding
drug evaluation, preclinical
adult

---
https://www.cadth.ca/fr/fidanacogene-elaparvovec
2023
false
false
false
Canada
French
Fidanacogene Elaparvovec
drug evaluation
hemophilia B
fidanacogene elaparvovec

---
Nous contacter.
01/11/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.